New ways to treat Duchenne muscular dystrophy

Duchenne muscular dystrophy (DMD) is a genetic disorder with progressive muscle degeneration and weakness due to changes in the protein dystrophin, which helps keep muscle cells intact. There are few treatments for DMD, although recent advances mean that males – who are primarily affected by DMD – can now sometimes survive into their 30s.More drugs are being developed in the fight against DMD, and this week we had a conversation with Frank Gleeson, CEO of Satellos Bioscience, about recent work on addressing DMD, including the company’s own work in the field.00:47-02:01: About Satellos Bioscience02:01-04:33: What is Duchenne muscular dystrophy?04:33-05:43: What are the challenges in treating Duchenne muscular dystrophy?05:43-09:08: What are the new treatments for Duchenne muscular dystrophy?  09:08-11:20: What is your treatment for Duchenne muscular dystrophy?11:20-13:42: Are there different approaches to treating Duchenne muscular dystrophy?13:42-14:06: How is your treatment delivered?14:06-17:32: How important is early intervention?17:32-18:56: Where is Satellos at with clinical trials?18:56-20:41: Preclinical trial results20:41-21:44: Outreach to the Duchenne muscular dystrophy community21:44-23:12: Is a cure for Duchenne muscular dystrophy possible?Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here! Stay updated by subscribing to our newsletter